• LAST PRICE
    66.4200
  • TODAY'S CHANGE (%)
    Trending Up0.5300 (0.8044%)
  • Bid / Lots
    57.7100/ 1
  • Ask / Lots
    106.2400/ 2
  • Open / Previous Close
    66.8300 / 65.8900
  • Day Range
    Low 64.9700
    High 67.5250
  • 52 Week Range
    Low 43.4600
    High 117.8600
  • Volume
    311,465
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 65.89
TimeVolumeBPMC
09:32 ET315366.83
09:34 ET50064.97
09:41 ET10065.5
09:43 ET70066.16
09:45 ET10066.16
09:48 ET50066.48
09:50 ET10066.51
09:56 ET40066.25
09:57 ET10066.285
09:59 ET10065.93
10:01 ET31566.26
10:06 ET30966.5
10:08 ET20066.74
10:10 ET52066.24
10:12 ET84066.78
10:14 ET30066.865
10:15 ET20066.58
10:19 ET20066.59
10:21 ET20066.68
10:24 ET10066.905
10:26 ET80066.945
10:28 ET10066.93
10:30 ET80066.51
10:32 ET53366.69
10:33 ET10066.92
10:35 ET30767.05
10:37 ET10067.205
10:39 ET40067.105
10:46 ET30067.07
10:48 ET30067.17
10:50 ET35067.225
10:51 ET892267.265
10:55 ET10067.525
10:57 ET80367.09
11:02 ET83767.235
11:04 ET40067.225
11:06 ET10067.245
11:08 ET168767.4
11:11 ET30067.46
11:13 ET10067.215
11:15 ET10067.185
11:18 ET50067.365
11:20 ET255966.995
11:22 ET365867.2
11:24 ET120067.13
11:26 ET10066.955
11:29 ET22666.985
11:31 ET10067
11:36 ET100066.9134
11:38 ET184966.765
11:40 ET40066.62
11:42 ET169566.675
11:44 ET70066.32
11:45 ET20065.975
11:51 ET10065.915
11:54 ET14165.75
11:56 ET21565.635
12:02 ET60065.66
12:03 ET60065.56
12:05 ET20065.52
12:07 ET10065.625
12:09 ET30065.72
12:12 ET20065.61
12:14 ET50065.6
12:18 ET20065.625
12:20 ET70065.405
12:21 ET10065.26
12:27 ET10065.2
12:30 ET10065.35
12:32 ET20065.29
12:34 ET10065.29
12:36 ET10065.33
12:38 ET40865.35
12:43 ET30065.43
12:48 ET60065.37
12:50 ET20065.39
12:54 ET10065.36
12:56 ET10065.32
12:57 ET100065.55
01:01 ET140065.689
01:03 ET343965.64
01:06 ET20065.74
01:08 ET10065.735
01:10 ET50065.8
01:14 ET10065.9
01:15 ET40065.89
01:17 ET20065.95
01:19 ET10065.88
01:24 ET260066.115
01:26 ET20066.21
01:32 ET40066.17
01:35 ET10066.32
01:37 ET60066.19
01:39 ET10066.07
01:44 ET60065.84
01:46 ET330065.815
01:48 ET20065.85
01:50 ET67565.69
01:51 ET10065.6634
01:53 ET10065.76
01:55 ET50065.42
01:57 ET20065.54
02:00 ET10065.5
02:02 ET10065.67
02:04 ET10065.62
02:09 ET10065.61
02:11 ET20065.66
02:13 ET680065.78
02:15 ET20065.75
02:18 ET63965.75
02:20 ET80065.69
02:22 ET155065.78
02:27 ET83565.9
02:29 ET40065.95
02:33 ET194066.04
02:36 ET10066.1
02:38 ET41266.11
02:40 ET20066.275
02:42 ET20066.23
02:44 ET30066.3
02:45 ET10066.31
02:47 ET20066.48
02:49 ET20066.435
02:51 ET12266.495
02:56 ET10066.61
02:58 ET30066.59
03:02 ET60066.47
03:05 ET392066.585
03:07 ET90066.6
03:09 ET30066.595
03:12 ET40066.58
03:14 ET70066.64
03:16 ET60066.54
03:18 ET50066.375
03:20 ET50066.33
03:21 ET10066.37
03:23 ET190066.22
03:25 ET10066.275
03:27 ET30066.26
03:30 ET82266.25
03:32 ET60066.26
03:36 ET71766.195
03:38 ET61066.195
03:39 ET40066.21
03:41 ET140066.155
03:43 ET50066.17
03:45 ET70066.36
03:48 ET70066.295
03:50 ET70066.39
03:52 ET290066.47
03:54 ET190266.36
03:56 ET345466.36
03:57 ET571366.34
03:59 ET9081266.42
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesBPMC
Blueprint Medicines Corp
3.8B
-5.6x
---
United StatesZLAB
Zai Lab Ltd
3.6B
-1.1x
---
United StatesMRTX
Mirati Therapeutics Inc
3.7B
-5.8x
---
United StatesITCI
Intra-Cellular Therapies Inc
4.0B
-12.9x
---
United StatesNTLA
Intellia Therapeutics Inc
4.1B
-10.4x
---
United StatesCCXI
ChemoCentryx Inc
3.7B
-27.5x
---
As of 2022-10-03

Company Information

Blueprint Medicines Corporation is a global precision therapy company that is inventing medicines for people with cancer and blood disorders. The Company delivers its approved medicines, including AYVAKIT/AYVAKYT (avapritinib) and GAVRETO (pralsetinib) to patients in the United States and Europe, and it is globally advancing multiple programs for systemic mastocytosis (SM), lung cancer and other genomically defined cancers, and cancer immunotherapy. Its pipelines also include BLU-263 (KIT), AYVAKIT (avapritinib) (PDGFRA), BLU-701 (EGFR), BLU-945 (EGFR), BLU-451 (EGFR exon 20 insertions), BLU-222 (CDK2) and BLU-852 (MAP4K1). It is developing and commercializing avapritinib for the treatment of advanced SM, and developing avapritinib for the treatment of non-advanced SM. The Company is developing BLU-263, an investigational, orally available KIT inhibitor, for the treatment of non-advanced SM and other mast cell disorders.

Contact Information

Headquarters
45 Sidney StreetCAMBRIDGE, MA, United States 02139
Phone
617-374-7580
Fax
302-655-5049

Executives

Executive Chairman of the Board
Jeffrey Albers
President, Chief Executive Officer, Director
Kathryn Haviland
Chief Financial Officer
Michael Landsittel
President - Research and Development
Fouad Namouni
Chief Operating Officer
Christina Rossi

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$3.8B
Revenue (TTM)
$230.5M
Shares Outstanding
59.7M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.80
EPS
$-11.87
Book Value
$16.41
P/E Ratio
-5.6x
Price/Sales (TTM)
16.4
Price/Cash Flow (TTM)
---
Operating Margin
-302.26%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.